| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥44.4B | ¥39.2B | +13.2% |
| Operating Income | ¥3.9B | ¥3.4B | +13.9% |
| Ordinary Income | ¥4.3B | ¥3.5B | +24.2% |
| Net Income | ¥2.6B | ¥2.1B | +26.3% |
| ROE | 15.1% | 12.5% | - |
FY2025 Q3 cumulative results: Revenue 44.4B yen (YoY +13.2%), Operating Income 3.9B yen (YoY +13.9%), Ordinary Income 4.3B yen (YoY +24.2%), Net Income 2.6B yen (YoY +26.3%). The company demonstrated solid growth across all profit lines, with bottom-line growth outpacing top-line expansion. Net profit margin improved by approximately 80 basis points to 5.8% from the prior year period, driven by non-operating income contributions and improved operational efficiency, despite a high effective tax rate of approximately 39.9% constraining further earnings growth.
Revenue increased 5.2B yen to 44.4B yen, representing 13.2% YoY growth. The HealthCare Solution segment drove the majority of revenue growth with sales of 31.8B yen (up 4.9B yen or 18.4% YoY), while the HomeCare segment contributed 12.5B yen (up 0.2B yen or 1.8% YoY). The segment notes indicate that HealthCare Solution acquired all shares of CentWorks Corporation in Q1, generating goodwill of 299.1 million yen, which contributed to revenue expansion in this core segment. Gross profit grew to 18.2B yen with margin of 41.1%, representing an improvement from the prior year driven by higher revenue absorption.
Operating income increased 0.5B yen to 3.9B yen (YoY +13.9%), with operating margin of 8.7% remaining essentially flat from the prior year's 8.6%. Selling, general and administrative expenses rose to 14.4B yen (32.5% of revenue), with corporate-level unallocated expenses increasing to 417.6 million yen from 356.2 million yen in the prior year. The segment profit margin spread highlights operational differences: HomeCare achieved 23.9% margin compared to HealthCare Solution's 15.8% margin, though both segments improved profitability YoY.
Ordinary income rose 0.8B yen to 4.3B yen (YoY +24.2%), outpacing operating income growth due to net non-operating income contribution of approximately 0.4B yen. Non-operating income totaled 0.7B yen while non-operating expenses were 0.2B yen, primarily interest expense. The delta between ordinary income (4.3B yen) and operating income (3.9B yen) of approximately 0.4B yen represents a material 10.3% uplift to operating profit, warranting attention to the sustainability of non-operating contributors.
Net income increased 0.5B yen to 2.6B yen (YoY +26.3%), with net margin improving to 5.8% from 5.4% in the prior year. The gap between profit before tax (4.3B yen) and net income (2.6B yen) reflects income tax expense of 1.7B yen, representing an effective tax rate of 39.9%. Extraordinary items showed offsetting effects: extraordinary income of 0.4B yen and extraordinary loss of 0.4B yen, which included impairment loss of 0.4B yen. Specifically, the company recorded impairment of 42.8 million yen on goodwill related to Seiko Giken due to revised business plans indicating originally projected revenues would not materialize. This non-recurring factor partially offset earnings but demonstrates prudent asset management. EPS increased 26.9% to 49.09 yen from 38.67 yen, exceeding net income growth due to favorable share count changes.
This represents a revenue up/profit up pattern, with accelerating bottom-line growth driven by operating leverage, non-operating income contributions, and one-time extraordinary item offsets.
The HealthCare Solution segment generated revenue of 31.8B yen (71.7% of total) and operating income of 5.0B yen with segment margin of 15.8%. This represents the core business and primary growth driver, with revenue increasing 4.9B yen (18.4% YoY) and segment profit rising 0.9B yen (22.5% YoY). The acquisition of CentWorks Corporation in Q1 contributed to this expansion. The HomeCare segment produced revenue of 12.5B yen (28.3% of total) and operating income of 3.0B yen with segment margin of 23.9%, demonstrating superior profitability despite smaller scale. HomeCare revenue grew modestly by 0.2B yen (1.8% YoY) while segment profit increased 0.2B yen (5.6% YoY). The 8.1 percentage point margin differential between segments (23.9% vs 15.8%) reflects the higher-margin nature of HomeCare operations, though HealthCare Solution's scale and growth trajectory position it as the earnings growth engine. Corporate unallocated expenses of 417.6 million yen reduced consolidated operating margin by approximately 9.4 percentage points from the segment profit level.
[Profitability] ROE of 15.1% demonstrates strong return on equity, driven by financial leverage of 2.63x amplifying a net profit margin of 5.8% and asset turnover of 0.98. Operating margin of 8.7% improved marginally from 8.6% YoY, while net margin expanded approximately 80 basis points to 5.8% from 5.0% YoY. The high effective tax rate of 39.9% constrains net profitability, as the tax burden coefficient of 0.599 indicates significant tax leakage. Gross margin of 41.1% provides reasonable operating leverage potential. [Cash Quality] Cash and deposits of 17.9B yen provide 2.38x coverage of short-term debt of 7.5B yen, indicating adequate liquidity buffers. [Investment Efficiency] Asset turnover of 0.98 reflects efficient asset utilization relative to revenue generation. Receivables turnover of approximately 84 days (DSO) exceeds efficient benchmarks and represents an area for working capital optimization. [Financial Health] Equity ratio of 38.1% indicates moderate capitalization with room for balance sheet strengthening. Current ratio of 140.8% provides acceptable short-term liquidity though below conservative thresholds of 150%. Debt-to-equity ratio of 0.75 remains in conservative territory. Interest coverage ratio of approximately 17x demonstrates comfortable debt servicing capacity with interest expense of 0.2B yen well-covered by operating profit.
Cash and deposits increased 3.9B yen YoY to 17.9B yen, representing 39.7% of total assets and demonstrating strong liquidity accumulation. The cash buildup reflects operating profit generation of 3.9B yen contributing to internal cash generation, though the conversion efficiency to cash cannot be verified without operating cash flow disclosure. Working capital movements show accounts receivable increased 1.8B yen to 10.2B yen, reflecting revenue growth but also indicating elongated collection cycles with DSO at approximately 84 days. Trade payables decreased slightly to 0.8B yen, suggesting limited working capital financing optimization. The company's short-term debt coverage ratio of 2.38x indicates strong liquidity position for near-term obligations. Total assets increased 1.8B yen to 45.1B yen, with the increment primarily attributable to goodwill rising 2.5B yen to 5.0B yen and intangible assets increasing 4.4B yen to 8.8B yen, both reflecting M&A activity. Long-term loans of 5.3B yen combined with short-term borrowings of 7.5B yen total interest-bearing debt of 12.8B yen, yielding a net debt position of negative 5.1B yen when offset by cash reserves. This net cash position provides financial flexibility for organic growth investment and strategic acquisitions.
Ordinary income of 4.3B yen versus operating income of 3.9B yen shows net non-operating contribution of approximately 0.4B yen, representing 10.3% uplift to operating profit and 0.9% of revenue. Non-operating income of 0.7B yen comprises primarily interest and dividend income along with other miscellaneous gains, while non-operating expenses of 0.2B yen consist mainly of interest expense on the 12.8B yen interest-bearing debt. The non-operating net contribution, while positive, represents a material portion of pre-tax profit that warrants scrutiny for sustainability versus core operating performance. Extraordinary items netted to near-zero impact with extraordinary income of 0.4B yen offsetting extraordinary loss of 0.4B yen, the latter including 42.8 million yen goodwill impairment on Seiko Giken. This non-recurring impairment reflects management's prudent asset quality assessment, though it signals integration challenges in prior acquisitions. The effective tax rate of 39.9% appears elevated and constrains earnings quality; normalizing to a statutory rate would imply materially higher net income. Without operating cash flow disclosure, earnings quality assessment from an accruals perspective remains incomplete, though the strong cash position of 17.9B yen and positive equity growth suggest underlying cash generation supports reported profits.
Full-year guidance calls for revenue of 60.1B yen, operating income of 5.3B yen, ordinary income of 5.3B yen, and net income of 3.1B yen. Q3 cumulative progress rates stand at 73.8% for revenue, 72.6% for operating income, 81.1% for ordinary income, and 83.5% for net income. Relative to the standard Q3 benchmark of 75%, revenue and operating income progress rates are slightly behind by 1-2 percentage points, suggesting Q4 acceleration is required to meet targets. However, ordinary income and net income are tracking 6-8 percentage points ahead of standard pace, indicating stronger-than-anticipated bottom-line progression. The company has not revised its forecasts this quarter, maintaining confidence in full-year targets. Achievement of guidance implies Q4 revenue of 15.7B yen, operating income of 1.4B yen, ordinary income of 1.0B yen, and net income of 0.5B yen. The sequential Q4 implied figures show lower profitability than Q1-Q3 average quarterly run rates, suggesting either conservatism in guidance or anticipated seasonal headwinds. EPS guidance of 58.61 yen implies full-year net income of 3.1B yen, consistent with the stated net income forecast. No material assumptions from forecast notes were disclosed beyond general forward-looking statement caveats.
Annual dividend forecast stands at 18.00 yen per share, comprising an interim dividend of 0 yen and year-end dividend of 18.00 yen. The company announced a dividend policy revision and upward revision (increase) in dividend forecast on February 13, 2026. Based on forecasted EPS of 58.61 yen, the implied payout ratio is 30.7%, which represents a conservative and sustainable distribution policy. Compared to the calculated payout ratio of 25.1% based on Q3 cumulative results (EPS of 49.09 yen and interim dividend of 0 yen plus projected year-end dividend of 12.00 yen initially), the upward revision to 18.00 yen reflects increased shareholder return commitment. The company's cash position of 17.9B yen provides ample dividend coverage, with indicated annual dividend payment of approximately 0.96B yen representing only 5.4% of cash reserves and well-covered by anticipated net income generation. No share buyback activity was disclosed for the period. The total return ratio equals the payout ratio of 30.7% in the absence of buybacks, indicating room for enhanced capital returns while maintaining balance sheet strength and growth investment capacity.
Business concentration risk in HealthCare Solution segment, which accounts for 71.7% of revenue, creates vulnerability to sector-specific headwinds or regulatory changes affecting healthcare markets. Any deterioration in this core segment would materially impact consolidated performance.
Goodwill and intangible asset impairment risk has materialized with 42.8 million yen impairment recorded on Seiko Giken goodwill in the current period. Total goodwill of 5.0B yen (11.1% of assets) and intangible assets of 8.8B yen (19.5% of assets) represent 30.6% of total assets, creating substantial exposure to future impairment if acquired businesses underperform projections.
Accounts receivable collection risk evidenced by DSO of 84 days, which significantly exceeds efficient benchmarks and ties up working capital. Elongated collection cycles increase credit risk exposure and could strain operating cash generation if receivables aging deteriorates or bad debt provisions increase.
[Industry Position] (Reference - Proprietary Analysis)
The company operates in the IT and telecommunications services industry. Profitability metrics show ROE of 15.1% substantially exceeding the industry median of 8.3% (2025-Q3, n=104), positioning in the upper quartile and demonstrating superior capital efficiency. Operating margin of 8.7% aligns closely with the industry median of 8.2% (IQR: 3.6%-18.0%), indicating competitive operational efficiency at the median level. Net profit margin of 5.8% falls slightly below the industry median of 6.0% (IQR: 2.2%-12.7%), suggesting room for improvement in tax efficiency or cost management relative to peers.
Financial health metrics reveal equity ratio of 38.1% below the industry median of 59.2% (IQR: 42.5%-72.7%), indicating higher financial leverage than typical industry participants. Current ratio of 140.8% (1.41x) also trails the industry median of 2.15x (IQR: 1.57x-3.62x), reflecting a more aggressive liquidity posture. Financial leverage of 2.63x exceeds the industry median of 1.66x (IQR: 1.36-2.32), confirming the company's above-average use of debt to amplify returns, which contributes to the superior ROE performance.
Efficiency metrics show asset turnover of 0.98 outpacing the industry median of 0.67 (IQR: 0.49-0.93), demonstrating efficient asset utilization and positioning in the upper quartile. Receivables turnover of 84 days compares unfavorably to the industry median of 61 days (IQR: 46-83 days), indicating slower collection efficiency that warrants attention. Revenue growth of 13.2% YoY exceeds the industry median of 10.4% (IQR: -1.2%-19.6%), confirming above-median growth momentum.
(Industry: IT and Telecommunications Services, Comparison: 2025-Q3 fiscal periods, Source: Proprietary analysis)
The company demonstrates strong top-line growth momentum of 13.2% YoY with operating leverage translating to accelerating bottom-line expansion, evidenced by net income growth of 26.3% outpacing revenue gains. The acquisition-driven strategy is evident through M&A activity generating 299.1 million yen in new goodwill from CentWorks acquisition, though prior acquisition integration challenges manifested in 42.8 million yen goodwill impairment on Seiko Giken, highlighting execution risks in the growth-through-acquisition model.
Profitability profile shows superior ROE of 15.1% driven substantially by financial leverage of 2.63x, which amplifies the underlying asset returns but also increases financial risk relative to the industry median leverage of 1.66x. The company's below-median equity ratio of 38.1% (vs industry 59.2%) and current ratio of 1.41x (vs industry 2.15x) reflect aggressive balance sheet management that enhances returns but reduces financial cushion. The high effective tax rate of 39.9% represents a structural earnings headwind, and normalization toward statutory rates could unlock meaningful earnings upside.
Working capital efficiency presents an opportunity area, with receivables collection at 84 days materially exceeding the industry median of 61 days. Optimization of collection processes could release trapped working capital and improve cash conversion. The upward dividend revision to 18.00 yen (from initial 12.00 yen expectation) with conservative 30.7% payout ratio signals management confidence in earnings sustainability while preserving capital for organic and inorganic growth initiatives.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.